Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Systemic reprogramming of monocytes in Crohn’s disease promotes their intestinal inflammatory function
Eve Hornsby, Radha Gadhok, Inva Hoti, Eva Wozniak, James R. Boot, Emma Connick, Paul Stevens, Holly Creed, Amy Lewis, Andrew Silver, James O. Lindsay, Andrew J. Stagg
Eve Hornsby, Radha Gadhok, Inva Hoti, Eva Wozniak, James R. Boot, Emma Connick, Paul Stevens, Holly Creed, Amy Lewis, Andrew Silver, James O. Lindsay, Andrew J. Stagg
View: Text | PDF
Research Article Immunology Inflammation

Systemic reprogramming of monocytes in Crohn’s disease promotes their intestinal inflammatory function

  • Text
  • PDF
Abstract

Bone marrow–derived circulating monocytes continuously replenish intestinal macrophages, which become dysregulated in inflammatory bowel disease (IBD) and contribute to disease pathology. The origins of this dysregulation remain poorly understood. Here, we investigate the reprogramming of circulating monocytes in IBD prior to tissue recruitment using single-cell transcriptomic, epigenomic, and functional approaches. We characterize blood monocyte heterogeneity in newly diagnosed, treatment-naive IBD patients and healthy controls and show that monocytes in Crohn’s disease (CD) display a distinct transcriptional profile and altered distributions across inferred developmental trajectories; less pronounced changes were observed in ulcerative colitis (UC). We link CD-associated transcriptional changes to alterations in chromatin accessibility and identify NF-κB, EGR, KLF, and AP-1 family transcription factors as putative regulators of an inflammatory gene program in blood monocytes from patients with CD. We uncover a potential role for IFN-γ in priming blood monocytes for inflammatory function in CD by limiting their capacity to be regulated by IL-10. Finally, we show that the transcriptional and functional alterations in monocytes from patients with CD are maintained in monocyte-derived cells from the intestine. Together these data suggest that intestinal macrophage dysfunction in CD is, at least in part, pre-established by systemic signals prior to tissue recruitment.

Authors

Eve Hornsby, Radha Gadhok, Inva Hoti, Eva Wozniak, James R. Boot, Emma Connick, Paul Stevens, Holly Creed, Amy Lewis, Andrew Silver, James O. Lindsay, Andrew J. Stagg

×

Figure 7

Functional modification of intestinal monocyte-derived cells in CD.

Options: View larger image (or click on image) Download as PowerPoint
Functional modification of intestinal monocyte-derived cells in CD.
(A) ...
(A) Flow cytometry gating of CD14hi, CD14lo, and CD14neg cells within the CD45+HLA-DR+FSCint–hi population of lamina propria cells (LPCs). Example from inflamed CD and from a non-IBD control are shown. (B) Mean fluorescence intensity (MFI) of CD64 (minus MFI of isotype control) in CD14hi, CD14lo, and CD14neg cells from non-IBD samples (n = 5). P value denotes the result of 1-way ANOVA with Holm-Šidák’s correction. (C) CD14hi, CD14lo, and CD14neg populations expressed as a proportion of HLA-DR+FSCint–hi LPCs from inflamed CD (n = 14) and non-IBD controls (Healthy; n = 17). (D) Percentage inhibition of LPS-induced intracellular TNF-α production by IL-10 in CD14hi and CD14lo LPCs from inflamed CD (n = 14) and non-IBD control biopsies (Healthy; n = 17). LPCs were stimulated for 3 hours with 1 ng/mL LPS in the presence and absence of 2 ng/mL IL-10. (C and D) Data were analyzed statistically by 2-way ANOVA with Šidák’s correction. (B–D) *P < 0.05. Box-and-whisker plots show the median (center line), 25th and 75th percentiles (box), and minimum and maximum values (whiskers). Individual data points are overlaid.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts